United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 5 minute read Technology Industry News Marvell bets on 2nm die-to-die interface: Can it solve AI’s power and bandwidth crisis? Marvell unveils a 64 Gbps 2nm die-to-die interface, promising higher bandwidth, lower power, and resilient AI chip scaling. Find out why investors are watching. byPallavi MadhirajuAugust 27, 2025